$KAI
KADANT INC Stock $kai

$kai Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000088634624000132 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$271.6M	$274.8M
YoY Change	10.84%	19.59%
Cost Of Revenue	$150.2M	$152.9M
YoY Change	8.43%	19.71%
Gross Profit	$121.4M	$121.9M
YoY Change	13.97%	19.44%
Gross Profit Margin	44.71%	44.36%
Selling, General & Admin	$69.04M	$70.00M
YoY Change	15.09%	19.54%
% of Gross Profit	56.85%	57.43%
Research & Development	$3.409M	$3.482M
YoY Change	0.03%	3.32%
% of Gross Profit	2.81%	2.86%
Depreciation & Amortization	$12.78M	$11.99M
YoY Change	55.09%	41.97%
% of Gross Profit	10.52%	9.84%
Operating Expenses	$72.45M	$73.49M
YoY Change	14.28%	18.66%
Operating Profit	$48.99M	$48.40M
YoY Change	13.52%	20.66%
Interest Expense	-$5.109M	-$4.833M
YoY Change	164.85%	133.37%
% of Operating Profit	-10.43%	-9.99%
Other Income/Expense, Net	-$16.00K	-$2.000K
YoY Change	-23.81%	-90.48%
Pretax Income	$43.86M	$43.57M
YoY Change	6.65%	14.58%
Income Tax	$11.96M	$11.99M
% Of Pretax Income	27.28%	27.53%
Net Earnings	$31.59M	$31.29M
YoY Change	6.23%	11.46%
Net Earnings / Revenue	11.63%	11.39%
Basic Earnings Per Share	$2.69	$2.66
Diluted Earnings Per Share	$2.68	$2.66
COMMON SHARES
Basic Shares Outstanding	11.74M shares	11.74M shares
Diluted Shares Outstanding	11.78M shares	11.77M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$89.73M	$75.18M
YoY Change	27.84%	-12.08%
Cash & Equivalents	$89.73M	$75.18M
Short-Term Investments
Other Short-Term Assets	$41.07M	$41.81M
YoY Change	-0.93%	0.16%
Inventory	$169.3M	$173.5M
Prepaid Expenses
Receivables	$169.5M	$164.8M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$428.5M	$413.5M
YoY Change	8.7%	1.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$174.6M	$174.2M
YoY Change	38.68%	44.82%
Goodwill	$493.1M	$478.0M
YoY Change	26.83%	23.24%
Intangibles	$292.2M	$289.7M
YoY Change	74.63%	69.02%
Long-Term Investments
YoY Change
Other Assets	$101.0M	$100.6M
YoY Change	18.49%	23.85%
Total Long-Term Assets	$1.061B	$1.043B
YoY Change	38.27%	37.03%
TOTAL ASSETS
Total Short-Term Assets	$428.5M	$413.5M
Total Long-Term Assets	$1.061B	$1.043B
Total Assets	$1.489B	$1.456B
YoY Change	28.23%	24.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$50.54M	$54.42M
YoY Change	3.32%	-6.08%
Accrued Expenses	$43.25M	$38.25M
YoY Change	35.14%	26.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.263M	$3.233M
YoY Change	-5.8%	-3.55%
Total Short-Term Liabilities	$50.54M	$54.42M
YoY Change	3.32%	-6.08%
LONG-TERM LIABILITIES
Long-Term Debt	$326.4M	$345.3M
YoY Change	110.44%	91.66%
Other Long-Term Liabilities	$249.6M	$238.0M
YoY Change	2.13%	-3.56%
Total Long-Term Liabilities	$576.0M	$583.2M
YoY Change	44.19%	36.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$50.54M	$54.42M
Total Long-Term Liabilities	$576.0M	$583.2M
Total Liabilities	$626.6M	$637.6M
YoY Change	39.73%	31.52%
SHAREHOLDERS EQUITY
Retained Earnings	$839.4M	$811.6M
YoY Change	17.95%	18.42%
Common Stock	$146.0K	$146.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$862.8M	$818.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.489B	$1.456B
YoY Change	28.23%	24.54%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$31.59M	$31.29M
YoY Change	6.23%	11.46%
Depreciation, Depletion And Amortization	$12.78M	$11.99M
YoY Change	55.09%	41.97%
Cash From Operating Activities	$52.48M	$28.07M
YoY Change	133.46%	-23.87%
INVESTING ACTIVITIES
Capital Expenditures	$4.185M	$4.974M
YoY Change	-52.32%	11.3%
Acquisitions
YoY Change
Other Investing Activities	-$10.17M	-$59.28M
YoY Change	-3073.1%	-197703.33%
Cash From Investing Activities	-$14.35M	-$64.25M
YoY Change	70.16%	1338.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-26.06M	29.93M
YoY Change	-9.48%	-207.84%
NET CHANGE
Cash From Operating Activities	52.48M	28.07M
Cash From Investing Activities	-14.35M	-64.25M
Cash From Financing Activities	-26.06M	29.93M
Net Change In Cash	12.06M	-6.257M
YoY Change	-181.77%	-208.22%
FREE CASH FLOW
Cash From Operating Activities	$52.48M	$28.07M
Capital Expenditures	$4.185M	$4.974M
Free Cash Flow	$48.29M	$23.09M
YoY Change	252.48%	-28.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	818386000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q2	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	523000	usd
CY2024Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1346000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5200000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	776240000	usd
	us-gaap	Profit Loss ProfitLoss	56559000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.64
	us-gaap	Dividends Dividends	7516000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1036000	usd
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	9319000	usd
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	523000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1346000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-15383000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	818386000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	684305000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	29946000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2023Q3	us-gaap	Dividends Dividends	3395000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2630000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-461000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	713025000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	655571000	usd
	us-gaap	Profit Loss ProfitLoss	58205000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.58
	us-gaap	Dividends Dividends	6789000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	971000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5067000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	713025000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates and Critical Accounting Policies</span></div>The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Although the Company makes every effort to ensure the accuracy of the estimates and assumptions used in the preparation of its condensed consolidated financial statements or in the application of accounting policies, if business conditions were different, or if the Company were to use different estimates and assumptions, it is possible that materially different amounts could be reported in the Company's condensed consolidated financial statements.
	us-gaap	Interest Paid Net InterestPaidNet	9703000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4443000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	23286000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	23792000	usd
	kai	Noncash Or Part Noncash Acquisition Value Of Assets Acquired Adjusted Net Of Measurement Period Adjustments NoncashOrPartNoncashAcquisitionValueOfAssetsAcquiredAdjustedNetOfMeasurementPeriodAdjustments	341105000	usd
	kai	Noncash Or Part Noncash Acquisition Value Of Assets Acquired Adjusted Net Of Measurement Period Adjustments NoncashOrPartNoncashAcquisitionValueOfAssetsAcquiredAdjustedNetOfMeasurementPeriodAdjustments	-270000	usd
	kai	Payments To Acquire Businesses Net Of Cash Acquired And Post Closing Adjustments Net PaymentsToAcquireBusinessesNetOfCashAcquiredAndPostClosingAdjustmentsNet	299892000	usd
	kai	Payments To Acquire Businesses Net Of Cash Acquired And Post Closing Adjustments Net PaymentsToAcquireBusinessesNetOfCashAcquiredAndPostClosingAdjustmentsNet	-277000	usd
	kai	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed And Noncontrolling Interests Acquired NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumedAndNoncontrollingInterestsAcquired	-41213000	usd
	kai	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed And Noncontrolling Interests Acquired NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumedAndNoncontrollingInterestsAcquired	7000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	618000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1134000	usd
	us-gaap	Stock Issued1 StockIssued1	5140000	usd
	us-gaap	Stock Issued1 StockIssued1	4717000	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3758000	usd
CY2023Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3395000	usd
	kai	Bank Guarantee Expiration Period BankGuaranteeExpirationPeriod	P12M
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66725000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103832000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76371000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3470000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2621000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3354000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70195000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106453000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79725000	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	71453000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	66738000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	38916000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	32147000	usd
CY2024Q2	us-gaap	Other Inventory Inventory At Off Site Premises OtherInventoryInventoryAtOffSitePremises	3350000	usd
CY2023Q4	us-gaap	Other Inventory Inventory At Off Site Premises OtherInventoryInventoryAtOffSitePremises	5182000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	63144000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	53792000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	173513000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	152677000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	460493000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	188137000	usd
CY2024Q2	kai	Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss	-10897000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	261459000	usd
CY2024Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	489552000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	188137000	usd
CY2024Q2	kai	Intangible Assets Excluding Goodwill Accumulated Foreign Currency Translation Gain Loss IntangibleAssetsExcludingGoodwillAccumulatedForeignCurrencyTranslationGainLoss	-11720000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	289695000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	313894000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	174282000	usd
CY2023Q4	kai	Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss	-8921000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	130691000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	342953000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	174282000	usd
CY2023Q4	kai	Intangible Assets Excluding Goodwill Accumulated Foreign Currency Translation Gain Loss IntangibleAssetsExcludingGoodwillAccumulatedForeignCurrencyTranslationGainLoss	-9385000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	159286000	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	477622000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	85538000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	392084000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	92095000	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-22000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-6122000	usd
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	85951000	usd
CY2024Q2	us-gaap	Goodwill Gross GoodwillGross	563573000	usd
CY2024Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	85538000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	478035000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8154000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7283000	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	2048000	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	3154000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1326000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	2335000	usd
	us-gaap	Standard Product Warranty Accrual Additions From Business Acquisition StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition	472000	usd
	us-gaap	Standard Product Warranty Accrual Additions From Business Acquisition StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition	0	usd
	us-gaap	Standard Product Warranty Accrual Foreign Currency Translation Gain Loss StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-219000	usd
	us-gaap	Standard Product Warranty Accrual Foreign Currency Translation Gain Loss StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss	97000	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	9129000	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8199000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	245053000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	523740000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474811000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	245053000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	523740000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474811000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	245053000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	523740000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474811000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	15144000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	8366000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	61829000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	79397000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	20212000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	57139000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	47228000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	27262000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.78
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.22
	kai	Bank Acceptance Maturity Period BankAcceptanceMaturityPeriod	P6M
CY2024Q2	us-gaap	Due From Customer Acceptances DueFromCustomerAcceptances	7574000	usd
CY2023Q4	us-gaap	Due From Customer Acceptances DueFromCustomerAcceptances	10826000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	31291000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	29734000	usd
	us-gaap	Net Income Loss NetIncomeLoss	55980000	usd
	us-gaap	Net Income Loss NetIncomeLoss	57809000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11743000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11704000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11734000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11693000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	23000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	19000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	21000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	16000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11766000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11723000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11755000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11709000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.66
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.94
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.66
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.54
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.76
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.94
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19846000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20945000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.26
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.26
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	1954000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1789000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	345268000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	110875000	usd
CY2024Q2	us-gaap	Debt Current DebtCurrent	3233000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	3209000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	342035000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	107666000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2884000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2648000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5299000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4886000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	13840000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M24D
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	274765000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	245053000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	523740000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474811000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	48401000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	43078000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	85328000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	83192000	usd
CY2024Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4833000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1929000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8891000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4000000	usd
CY2024Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	2000	usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	21000	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	32000	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	42000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	43566000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	41128000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	76405000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	79150000	usd
CY2024Q2	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	4974000	usd
CY2023Q3	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	8777000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	11245000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	13246000	usd
CY2024Q2	us-gaap	Assets Assets	1456032000	usd
CY2023Q4	us-gaap	Assets Assets	1175665000	usd
	kai	Bank Acceptance Maturity Period BankAcceptanceMaturityPeriod	P6M
CY2024Q2	us-gaap	Bank Acceptances Executed BankAcceptancesExecuted	5162000	usd
CY2023Q4	us-gaap	Bank Acceptances Executed BankAcceptancesExecuted	9090000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000886346-24-000132-index-headers.html	Edgar Link	pending
0000886346-24-000132-index.html	Edgar Link	pending
0000886346-24-000132.txt	Edgar Link	pending
0000886346-24-000132-xbrl.zip	Edgar Link	pending
exhibit102seventhamendme.htm	Edgar Link	pending
exhibit102seventhamendme001.jpg	Edgar Link	pending
exhibit102seventhamendme002.jpg	Edgar Link	pending
exhibit102seventhamendme003.jpg	Edgar Link	pending
exhibit102seventhamendme004.jpg	Edgar Link	pending
exhibit102seventhamendme005.jpg	Edgar Link	pending
exhibit102seventhamendme006.jpg	Edgar Link	pending
exhibit102seventhamendme007.jpg	Edgar Link	pending
exhibit102seventhamendme008.jpg	Edgar Link	pending
exhibit102seventhamendme009.jpg	Edgar Link	pending
exhibit102seventhamendme010.jpg	Edgar Link	pending
exhibit102seventhamendme011.jpg	Edgar Link	pending
exhibit102seventhamendme012.jpg	Edgar Link	pending
exhibit102seventhamendme013.jpg	Edgar Link	pending
exhibit102seventhamendme014.jpg	Edgar Link	pending
exhibit102seventhamendme015.jpg	Edgar Link	pending
exhibit102seventhamendme016.jpg	Edgar Link	pending
exhibit102seventhamendme017.jpg	Edgar Link	pending
exhibit102seventhamendme018.jpg	Edgar Link	pending
exhibit102seventhamendme019.jpg	Edgar Link	pending
exhibit102seventhamendme020.jpg	Edgar Link	pending
exhibit102seventhamendme021.jpg	Edgar Link	pending
exhibit102seventhamendme022.jpg	Edgar Link	pending
exhibit102seventhamendme023.jpg	Edgar Link	pending
exhibit102seventhamendme024.jpg	Edgar Link	pending
exhibit102seventhamendme025.jpg	Edgar Link	pending
exhibit102seventhamendme026.jpg	Edgar Link	pending
exhibit102seventhamendme027.jpg	Edgar Link	pending
exhibit102seventhamendme028.jpg	Edgar Link	pending
exhibit102seventhamendme029.jpg	Edgar Link	pending
exhibit102seventhamendme030.jpg	Edgar Link	pending
exhibit102seventhamendme031.jpg	Edgar Link	pending
exhibit102seventhamendme032.jpg	Edgar Link	pending
exhibit102seventhamendme033.jpg	Edgar Link	pending
exhibit102seventhamendme034.jpg	Edgar Link	pending
exhibit102seventhamendme035.jpg	Edgar Link	pending
exhibit102seventhamendme036.jpg	Edgar Link	pending
exhibit102seventhamendme037.jpg	Edgar Link	pending
exhibit102seventhamendme038.jpg	Edgar Link	pending
exhibit102seventhamendme039.jpg	Edgar Link	pending
exhibit102seventhamendme040.jpg	Edgar Link	pending
exhibit102seventhamendme041.jpg	Edgar Link	pending
exhibit102seventhamendme042.jpg	Edgar Link	pending
exhibit102seventhamendme043.jpg	Edgar Link	pending
exhibit102seventhamendme044.jpg	Edgar Link	pending
exhibit102seventhamendme045.jpg	Edgar Link	pending
exhibit102seventhamendme046.jpg	Edgar Link	pending
exhibit102seventhamendme047.jpg	Edgar Link	pending
exhibit102seventhamendme048.jpg	Edgar Link	pending
exhibit102seventhamendme049.jpg	Edgar Link	pending
exhibit102seventhamendme050.jpg	Edgar Link	pending
exhibit102seventhamendme051.jpg	Edgar Link	pending
exhibit102seventhamendme052.jpg	Edgar Link	pending
exhibit102seventhamendme053.jpg	Edgar Link	pending
exhibit102seventhamendme054.jpg	Edgar Link	pending
exhibit102seventhamendme055.jpg	Edgar Link	pending
exhibit102seventhamendme056.jpg	Edgar Link	pending
exhibit102seventhamendme057.jpg	Edgar Link	pending
exhibit102seventhamendme058.jpg	Edgar Link	pending
exhibit102seventhamendme059.jpg	Edgar Link	pending
exhibit102seventhamendme060.jpg	Edgar Link	pending
exhibit102seventhamendme061.jpg	Edgar Link	pending
exhibit102seventhamendme062.jpg	Edgar Link	pending
exhibit102seventhamendme063.jpg	Edgar Link	pending
exhibit102seventhamendme064.jpg	Edgar Link	pending
exhibit102seventhamendme065.jpg	Edgar Link	pending
exhibit102seventhamendme066.jpg	Edgar Link	pending
exhibit102seventhamendme067.jpg	Edgar Link	pending
exhibit102seventhamendme068.jpg	Edgar Link	pending
exhibit102seventhamendme069.jpg	Edgar Link	pending
exhibit102seventhamendme070.jpg	Edgar Link	pending
exhibit102seventhamendme071.jpg	Edgar Link	pending
exhibit102seventhamendme072.jpg	Edgar Link	pending
exhibit102seventhamendme073.jpg	Edgar Link	pending
exhibit102seventhamendme074.jpg	Edgar Link	pending
exhibit102seventhamendme075.jpg	Edgar Link	pending
exhibit102seventhamendme076.jpg	Edgar Link	pending
exhibit102seventhamendme077.jpg	Edgar Link	pending
exhibit102seventhamendme078.jpg	Edgar Link	pending
exhibit102seventhamendme079.jpg	Edgar Link	pending
exhibit102seventhamendme080.jpg	Edgar Link	pending
exhibit102seventhamendme081.jpg	Edgar Link	pending
exhibit102seventhamendme082.jpg	Edgar Link	pending
exhibit102seventhamendme083.jpg	Edgar Link	pending
exhibit102seventhamendme084.jpg	Edgar Link	pending
exhibit102seventhamendme085.jpg	Edgar Link	pending
exhibit102seventhamendme086.jpg	Edgar Link	pending
exhibit102seventhamendme087.jpg	Edgar Link	pending
exhibit102seventhamendme088.jpg	Edgar Link	pending
exhibit102seventhamendme089.jpg	Edgar Link	pending
exhibit102seventhamendme090.jpg	Edgar Link	pending
exhibit102seventhamendme091.jpg	Edgar Link	pending
exhibit102seventhamendme092.jpg	Edgar Link	pending
exhibit102seventhamendme093.jpg	Edgar Link	pending
exhibit102seventhamendme094.jpg	Edgar Link	pending
exhibit102seventhamendme095.jpg	Edgar Link	pending
exhibit102seventhamendme096.jpg	Edgar Link	pending
exhibit102seventhamendme097.jpg	Edgar Link	pending
exhibit102seventhamendme098.jpg	Edgar Link	pending
exhibit102seventhamendme099.jpg	Edgar Link	pending
exhibit102seventhamendme100.jpg	Edgar Link	pending
exhibit102seventhamendme101.jpg	Edgar Link	pending
exhibit102seventhamendme102.jpg	Edgar Link	pending
exhibit102seventhamendme103.jpg	Edgar Link	pending
exhibit102seventhamendme104.jpg	Edgar Link	pending
exhibit102seventhamendme105.jpg	Edgar Link	pending
exhibit102seventhamendme106.jpg	Edgar Link	pending
exhibit102seventhamendme107.jpg	Edgar Link	pending
exhibit102seventhamendme108.jpg	Edgar Link	pending
exhibit102seventhamendme109.jpg	Edgar Link	pending
exhibit102seventhamendme110.jpg	Edgar Link	pending
exhibit102seventhamendme111.jpg	Edgar Link	pending
exhibit102seventhamendme112.jpg	Edgar Link	pending
exhibit102seventhamendme113.jpg	Edgar Link	pending
exhibit102seventhamendme114.jpg	Edgar Link	pending
exhibit102seventhamendme115.jpg	Edgar Link	pending
exhibit102seventhamendme116.jpg	Edgar Link	pending
exhibit102seventhamendme117.jpg	Edgar Link	pending
exhibit102seventhamendme118.jpg	Edgar Link	pending
exhibit102seventhamendme119.jpg	Edgar Link	pending
exhibit102seventhamendme120.jpg	Edgar Link	pending
exhibit102seventhamendme121.jpg	Edgar Link	pending
exhibit102seventhamendme122.jpg	Edgar Link	pending
exhibit102seventhamendme123.jpg	Edgar Link	pending
exhibit102seventhamendme124.jpg	Edgar Link	pending
exhibit102seventhamendme125.jpg	Edgar Link	pending
exhibit102seventhamendme126.jpg	Edgar Link	pending
exhibit102seventhamendme127.jpg	Edgar Link	pending
exhibit102seventhamendme128.jpg	Edgar Link	pending
exhibit102seventhamendme129.jpg	Edgar Link	pending
exhibit102seventhamendme130.jpg	Edgar Link	pending
exhibit102seventhamendme131.jpg	Edgar Link	pending
exhibit102seventhamendme132.jpg	Edgar Link	pending
exhibit102seventhamendme133.jpg	Edgar Link	pending
exhibit102seventhamendme134.jpg	Edgar Link	pending
exhibit102seventhamendme135.jpg	Edgar Link	pending
exhibit102seventhamendme136.jpg	Edgar Link	pending
exhibit102seventhamendme137.jpg	Edgar Link	pending
exhibit102seventhamendme138.jpg	Edgar Link	pending
exhibit102seventhamendme139.jpg	Edgar Link	pending
exhibit102seventhamendme140.jpg	Edgar Link	pending
exhibit102seventhamendme141.jpg	Edgar Link	pending
exhibit102seventhamendme142.jpg	Edgar Link	pending
exhibit102seventhamendme143.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kai-20240629.htm	Edgar Link	pending
kai-20240629.xsd	Edgar Link	pending
kaiform10q2q2024ex311.htm	Edgar Link	pending
kaiform10q2q2024ex312.htm	Edgar Link	pending
kaiform10q2q2024ex32.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
kai-20240629_cal.xml	Edgar Link	unprocessable
kai-20240629_def.xml	Edgar Link	unprocessable
kai-20240629_lab.xml	Edgar Link	unprocessable
kai-20240629_pre.xml	Edgar Link	unprocessable
kai-20240629_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KAI
KADANT INC Stock $kai

2024 Q3 Form 10-Q Financial Statement

#000088634624000132 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAI KADANT INC Stock $kai

2024 Q3 Form 10-Q Financial Statement

#000088634624000132 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAI
KADANT INC Stock $kai